INDUSTRY EXPERT ARTICLES

Holden writes, “Resilient Lifescience co-founder Charlie Proctor and I became alarmed by the 22% surge in synthetic opioid deaths during the COVID-19 pandemic and set out to leverage our experience in remote patient monitoring and computer science to develop a solution — a wearable medical device designed to detect and reverse opioid overdoses. Read on to learn how Resilient Lifescience is making a difference!

Length of stay is both a direct and indirect factor in efficient and effective hospital operations. However, it may be an even more substantial clinical metric today than hospital administrators, management, and executives realize. The impact can be considerable when ignored or de-prioritized. Read on.

Kelly Snow writes, “With effort, practical solutions, and leadership, I am optimistic we can improve representation in clinical trials, to increase access to and effectiveness of life- saving medications.” Read on:

The newly published report relies on data collected from 44 organizations that employ more than 15,000 technicians, including analysis of more than 4.6 million work orders covering more than $3.4 billion in total service costs.

Kyle Forcier shares the most pressing industry challenges and what device manufacturers can do to ensure greater profitability in the near and long term. Read on.

Ofer Sharon, MD, CEO of OncoHost provides his expert views on where this all began and where things are heading. Read on.